Literature DB >> 9686358

Phenotypic characterization of mice with targeted disruption of glycosylasparaginase gene: a mouse model for aspartylglycosaminuria.

V Kaartinen1, I Mononen, I Gonzalez-Gomez, T Noronkoski, N Heisterkamp, J Groffen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9686358     DOI： 10.1023/a:1005387215224

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Aspartylglycosaminuria: a generalized storage disease. Morphological and histochemical studies.

Authors:  M Haltia; J Palo; S Autio
Journal:  Acta Neuropathol       Date:  1975       Impact factor: 17.088

2.  A mouse model for the human lysosomal disease aspartylglycosaminuria.

Authors:  V Kaartinen; I Mononen; J W Voncken; T Noronkoski; I Gonzalez-Gomez; N Heisterkamp; J Groffen
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

Review 3.  Aspartylglycosaminuria: protein chemistry and molecular biology of the most common lysosomal storage disorder of glycoprotein degradation.

Authors:  I Mononen; K J Fisher; V Kaartinen; N N Aronson
Journal:  FASEB J       Date:  1993-10       Impact factor: 5.191
  3 in total
  2 in total

Review 1.  Aspartylglycosaminuria: a review.

Authors:  Maria Arvio; Ilkka Mononen
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

2.  Pre-clinical Gene Therapy with AAV9/AGA in Aspartylglucosaminuria Mice Provides Evidence for Clinical Translation.

Authors:  Xin Chen; Sarah Snanoudj-Verber; Laura Pollard; Yuhui Hu; Sara S Cathey; Ritva Tikkanen; Steven J Gray
Journal:  Mol Ther       Date:  2020-11-11       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.